We develop bespoke biomarker tests to identify patients and demonstrate treatment efficacy for novel therapeutics. Our tests support pharmaceutical companies in running successful clinical trials and in maximising access to marketed therapies.

London, UK

Inoviv

Ambitious individuals leave places like Google, Goldman Sachs and Stanford to join EF. Why? Because starting a startup is the highest impact thing you can do with your life.    EF is the best place to find a co-founder, build a company and access the world's best investors. We've helped build over 80 technology companies, collectively worth over $1bn.
EF is backed by Reid Hoffman (founder of LinkedIn) and Greylock Partners, Mosaic Ventures, Founders Fund, Lakestar and some of the world's best entrepreneurs.
Read our manifesto here.

Join aworld-changingstartup

Join a
world-changing
startup